Economy desk · Fewer than 10 votes on record · closed Oct 6

Do you support or oppose most-favored-nation drug pricing, under which drugmakers charge U.S. programs no more than they charge in other developed countries?

More than 20 pharmaceutical companies have announced agreements with the federal government to offer certain prescription drugs at most-favored-nation prices — prices no higher than those charged in other developed countries — including sales to state Medicaid programs and through a federal direct-to-consumer website, in exchange for tariff relief.